Tonix Pharmaceuticals Holding Corp. Stock
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Tonix Pharmaceuticals Holding Corp. stock is not clear.
Based on the current price of 2.82 € the target price of 64 € shows a potential of 2169.5% for Tonix Pharmaceuticals Holding Corp. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Tonix Pharmaceuticals Holding Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Tonix Pharmaceuticals Holding Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tonix Pharmaceuticals Holding Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | - | - | - | - | - | - | - |
| Ardelyx Inc. | -1.330% | 4.231% | 4.603% | 5.906% | 6.183% | 185.065% | -8.694% |
| Krystal Biotech | -0.860% | 2.833% | 17.993% | 32.628% | 35.940% | 191.408% | - |
| Evolus Inc | 0.860% | 1.754% | -5.691% | -45.794% | -44.762% | -10.769% | 86.435% |
Comments
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "buy" rating re-affirmed by analysts at Alliance Global Partners.
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "outperform" rating re-affirmed by analysts at Noble Financial. They now have a $70.00 price target on the stock.
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for TNXP provided by MarketBeat
